Ashvattha Therapeutics

0 followers


Ashvattha Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel hydroxyl dendrimer (HD) therapeutics (HDTs) to treat unmet medical needs in oncology, ophthalmology, and inflammatory diseases.

Industries

Headquarters

Stage

Employees

Links

Org chart

Jeffrey L. Cleland
Chairman, President & CEO

Jeffrey L. Cleland

Collapse
Steve Carlos
VP, Manufacturing
Elizabeth Torrelio
Head, Program Management
Natacha Le Moan
Head, Translational Biology
Debra Nguyen
Sr. Manager, Accounting
Jay Z.
Board Director
Jeannie Skinner
Head of Regulatory Affairs
Jennifer Herber
Associate Director
Mark Feng
Director, Analytical Development
Christine S.
Director, Project Management
Naze Gul Avci, Ph.D.
Senior Scientist